Summer orders are particularly vulnerable to heat degradation during extended customs holds
As part of Eli Lillys campaign against compounded GLP-1s, the company conducted testing of products marketed to contain tirzepatide and B12
Back Eng, J, Kleinman, WA, Singh, L, et al (April 1992) 'Isolation and characterisation of Exendin-4, an Exendin-3 analogue, from heloderma suspectum venom', The Journal of Biological Chemistry , 267/11, 7402-06
Future outlook Research into GLP-1 patches is progressing quickly, with several pharmaceutical companies reporting positive results from preclinical and early human studies
Studies suggest that a high-protein breakfast led to raised GLP-1 levels that remained higher throughout the 4-hour study
[11] Any future GLP-1 patch would require robust clinical trial evidence demonstrating efficacy, safety, and pharmacokinetic profiles comparable to existing injectable formulations before regulatory approval could be granted